Human cancer cells commonly acquire DNA damage during mitotic arrest

Area of Science:

• Cell Biology
• Genetics
• Cancer Research

Background:

• The mitotic checkpoint ensures proper chromosome attachment to spindle fibers, preventing premature anaphase.
• Defects in the mitotic checkpoint are linked to cancer development.
• Antimitotic drugs, which disrupt chromosome-spindle interactions, are used in cancer therapy, but their toxicity mechanisms are unclear.

Purpose of the Study:

• To investigate the consequences of mitotic arrest on chromosome integrity.
• To determine if mitotic arrest can induce DNA damage.
• To explore the potential role of DNA damage in tumorigenesis and antimitotic drug toxicity.

Main Methods:

• Pharmacologic and genetic induction of mitotic arrest in human cancer cells.
• Analysis of DNA breaks and DNA damage response activation.
• Assessment of karyotype alterations and spontaneous breakage in cancer cells with spindle abnormalities.
• Examination of primary human cells for DNA breakage.

Main Results:

• Mitotic arrest, whether pharmacologic or genetic, leads to DNA breaks in mitotic chromosomes of human cancer cells.
• These DNA breaks trigger a DNA damage response independently of cell death.
• The induced DNA breaks result in karyotype alterations and can also occur spontaneously, particularly in cells with spindle defects.
• Evidence of DNA breakage was also observed in primary human cells.

Conclusions:

• Mitotic arrest is a novel source of DNA damage in human cells.
• DNA breaks induced by mitotic arrest may contribute to cancer progression.
• This mechanism could also underlie the toxicity of antimitotic drugs used in cancer treatment.